Clinical Trial Update: A Phase 1/2, RU-101 Ophthalmic Solution in Patients With Severe Dry Eye [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of RU-101 ophthalmic solution for severe dry eye has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye

Drugs mentioned

• RU-101

Snippet

Sponsor: R-Tech Ueno, Ltd. | Conditions: Dry Eye | Phase 1, Phase 2 | Status: COMPLETED